Works matching IS 0008543X AND DT 2005 AND VI 104 AND IP 9

Results: 34
    1
    2
    3
    4
    5

    Developing a cancer‐specific geriatric assessmentPresented at the 40th annual meeting of the American Society of Clinical Oncology, New Orleans, Louisiana, June 5–8, 2004.: A feasibility study.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 9, p. 1998, doi. 10.1002/cncr.21422
    By:
    • Arti Hurria;
    • Supriya Gupta;
    • Marjorie Zauderer;
    • Enid L. Zuckerman;
    • Harvey J. Cohen;
    • Hyman Muss;
    • Miriam Rodin;
    • Katherine S. Panageas;
    • Jimmie C. Holland;
    • Leonard Saltz;
    • Mark G. Kris;
    • Ariela Noy;
    • Jorge Gomez;
    • Ann Jakubowski;
    • Clifford Hudis;
    • Alice B. Kornblith
    Publication type:
    Article
    6
    7

    Surgeon perspectives about local therapy for breast carcinomaThe collection of cancer incidence data used in the current study was supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885.The ideas and opinions expressed herein are those of the author, and no endorsement by the State of California, Department of Health Services, is intended or should be inferred.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 9, p. 1854, doi. 10.1002/cncr.21396
    By:
    • Steven J. Katz;
    • Paula M. Lantz;
    • Nancy K. Janz;
    • Angela Fagerlin;
    • Kendra Schwartz;
    • Lihua Liu;
    • Dennis Deapen;
    • Barbara Salem;
    • Indu Lakhani;
    • Monica Morrow
    Publication type:
    Article
    8
    9
    10

    Mature T‐cell leukemias.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 9, p. 1808, doi. 10.1002/cncr.21405
    By:
    • Farhad Ravandi;
    • Hagop Kantarjian;
    • Dan Jones;
    • Claire Dearden;
    • Michael Keating;
    • Susan O'Brien
    Publication type:
    Article
    11

    Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary siteThe following institutions are Minnie Pearl Cancer Research Network Participating Sites: Tennessee Oncology, PLLC (Nashville, TN); Wellstar Cancer Research (Marietta, GA); Consultants in Blood Disorders & Cancer (Louisville, KY); Graves‐Gilbert Clinic (Bowling Green, KY); Grand Rapids CCOP (Grand Rapids, MI); Upstate Carolina CCOP (Spartanburg, SC); Northeast Georgia Medical Center (Gainesville, GA); King's Daughters' Medical Center (Ashland, KY); Pheobe Cancer Center (Albany, GA); The Reading Hospital and Medical Center (Reading, PA); and Montana Cancer Specialists (Missoula, MT).: A Minnie Pearl Cancer Research Network Phase II trial

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 9, p. 1992, doi. 10.1002/cncr.21416
    By:
    • John D. Hainsworth;
    • David R. Spigel;
    • Eric L. Raefsky;
    • Michel E. Kuzur;
    • Kathleen Yost;
    • Michael Kommor;
    • Sharlene Litchy;
    • F. Anthony Greco
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    Increased incidence of melanoma in renal transplantation recipientsThe data reported here have been supplied by the United States Renal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the U.S. government.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 9, p. 1962, doi. 10.1002/cncr.21404
    By:
    • Christopher S. Hollenbeak;
    • Michael M. Todd;
    • Elizabeth M. Billingsley;
    • Gregory Harper;
    • Anne‐Marie Dyer;
    • Eugene J. Lengerich
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Author reply.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 9, p. 2033, doi. 10.1002/cncr.21460
    By:
    • R.I. Portin;
    • H.Y.M. Helenius;
    • Eeva K. Salminen
    Publication type:
    Article
    30
    31
    32
    33
    34